DigraphOrganize the world
Digraph

Search

BlogRecentEverythingSign in
Recent activity

Activity

2 years ago

Eric Walker added Keith Kaye, MD, MPH, on the Approval of Imipenem/Cilastatin + Relebactam to a number of topics

2 years ago

Eric Walker added Keith S. Kaye, MD, MPH: RESTORE-IMI 2 and Treating Critically Ill Patients With Respiratory Infections to a number of topics

2 years ago

Eric Walker added Keith S. Kaye, MD, MPH: RESTORE-IMI 2 and Treating Critically Ill Patients With Respiratory Infections and Keith Kaye, MD, MPH, on the Approval of Imipenem/Cilastatin + Relebactam to AmpC cephalosporinase, and added AmpC cephalosporinase to Cephalosporinases

2 years ago

Eric Walker added L2 β-lactamase and AmpC cephalosporinase and Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens and Resistance to last resort drug arose in patient over 3 weeks to Cephalosporinases, and added Cephalosporinases to Extended spectrum beta-lactamases (ESBL) and Cephalosporins

Terms・ Software available under the MIT license. © Eric Walker.